Shedir Pharma Srl Unipersonale
MIL:SHE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Remy Cointreau SA
OTC:REMYF
|
FR |
|
Ningbo Exciton Technology Co Ltd
SZSE:300566
|
CN |
|
W
|
Wah Wo Holdings Group Ltd
HKEX:9938
|
HK |
Shedir Pharma Srl Unipersonale
Other Current Liabilities
Shedir Pharma Srl Unipersonale
Other Current Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Shedir Pharma Srl Unipersonale
MIL:SHE
|
Other Current Liabilities
€849k
|
CAGR 3-Years
4%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
N/A
|
|
|
Newron Pharmaceuticals SpA
SIX:NWRN
|
Other Current Liabilities
€6.8m
|
CAGR 3-Years
105%
|
CAGR 5-Years
26%
|
CAGR 10-Years
N/A
|
|
|
Recordati Industria Chimica e Farmaceutica SpA
MIL:REC
|
Other Current Liabilities
€275.9m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
11%
|
CAGR 10-Years
9%
|
|
Shedir Pharma Srl Unipersonale
Glance View
Shedir Pharma Group SpA operates as a holding company which engages in the research and development of nutraceuticals and medical devices. The company is headquartered in Mercato San Severino, Salerno and currently employs 71 full-time employees. The company went IPO on 2019-07-23. The firm markets its products in different forms and under the brand lines Shedir Farmaceutici, Deimos Farmaceutici, Phobos Farmaceutici, Menkar Farmaceutici and Greenplanet Divisione Farmaceutica. Its products cover a wide range of therapeutics areas, such as cardiovascular, dermatology, neurology, urology, gynecology and dental health, among others.
See Also
What is Shedir Pharma Srl Unipersonale's Other Current Liabilities?
Other Current Liabilities
849k
EUR
Based on the financial report for Dec 31, 2023, Shedir Pharma Srl Unipersonale's Other Current Liabilities amounts to 849k EUR.
What is Shedir Pharma Srl Unipersonale's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 5Y
-20%
Over the last year, the Other Current Liabilities growth was -36%. The average annual Other Current Liabilities growth rates for Shedir Pharma Srl Unipersonale have been 4% over the past three years , -20% over the past five years .
